Chat with us, powered by LiveChat
Micro Market Research
+1-888-502-0539
US/CAN Toll Free

You are here :   Home     Press Releases   >   Global Intrauterine Contraceptive Devices Market worth $4,605.6 Million by 2019
Connect With Us
US/CAN : +1-888-502-0539

Global Intrauterine Contraceptive Devices Market worth $4,605.6 Million by 2019


The Report “Global intrauterine contraceptive devices market by Type [Hormonal IUCD, Copper IUCD] – Global Forecast to 2019” is estimated to reach $4,605.6 million by 2019, at a CAGR of 6.8% from 2014 to 2019.

                                                   

Browse through the TOC of the Global Intrauterine Contraceptive Devices Market for an analysis of industry trends and segments, with the help of various tables and figures.

                                 Early buyers will receive 10% customization on this report

Intrauterine device (IUCD) is a small contraceptive device that is inserted into the uterus to prevent pregnancy. The IUCDs are available in two types namely, copper and hormonal. The hormonal IUCD contains progesterone, which is a synthetic version of the naturally occurring hormone progesterone. Both these types are very effective methods of contraception and can stay in place for an average of at least five years.

The factors driving the intrauterine contraceptive devices market include increasing rate of unplanned pregnancies, effective contraceptive method, and less side effects as compared to other contraceptive methods. In the U.S., around 82% of the adolescent pregnancies are unplanned. The users, especially adolescents trust the intrauterine devices market, as it is extremely reliable and effective. As a result, long-acting reversible contraception (LARC) methods, such as intrauterine contraceptive devices are adopted on a large scale.

The market in Asia contributed the maximum share of 35.0% to the intrauterine contraceptive devices market globally, as of 2014.

IUCD is safe and more effective than other contraceptives, such as oral contraceptives, as the other contraceptives have several side effects, such as dizziness, headache, lightheadedness, stomach upset, bloating, or nausea.

This market is segmented and forecast on the basis of different type and products. The market based on products includes Mirena, Skyla, Paragard, Essure, and pipeline product Livosert. The market is further segmented and forecast on the basis of major regions, such as the Asia, Europe, North America, and Rest of the World (RoW).

This report also includes the market share, value chain analyses, usage percentage and sales of different products, market metrics such as drivers, restraints and also the upcoming opportunities in the market. In addition, it presents a competitive landscape and company profiles of the key players in the market.

About MicroMarket Monitor:

MicroMarket Monitor identifies and attends to various unmet needs of different industrial verticals, which include value chain impact analysis. The company publishes about 12000 Market Research Reports on various Micro Markets across the world. The graphical nature and multidimensional analysis of these reports provide advanced Business Intelligence Tools to the clients in that particular target market.

Contact:

Mr. Chandrasekhar K.
UNIT no 802, Tower No. 7, SEZ
Magarpatta City, Hadapsar
Pune, Maharashtra 411013, India
Tel: +1-888-502-0539
Email: sales@micromarketmonitor.com